Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Access to Medicine Versus Test Data Exclusivity - Owais H. Shaikh

Access to Medicine Versus Test Data Exclusivity

Safeguarding Flexibilities Under International Law

(Autor)

Buch | Softcover
XVI, 256 Seiten
2018 | 1. Softcover reprint of the original 1st ed. 2016
Springer Berlin (Verlag)
978-3-662-57021-0 (ISBN)
CHF 149,75 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
This book explores the concept of test data exclusivity protection for pharmaceuticals. Focusing on Art 39(3) of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) and relevant provisions in selected free trade agreements (FTA) and national laws, it combines normative, historical, comparative and economic analysis of test data exclusivity protection.At the heart of this book is the novel and original Index of Data Exclusivity and Access (IDEAS), which analyzes the effectiveness of test data exclusivity provisions in FTAs and national laws both on the strength of exclusivity as well as on access to medicine. IDEAS provides a framework for the assessment of current test data exclusivity protection standards on the basis of their proximity to Article 39(3) of the TRIPS Agreement, the scope of exclusivity and the flexibilities in FTAs, and subsequently in national laws. This book aims to broaden national and international policy makers' grasp of the various nuances of test data exclusivity protection. Furthermore, it provides practical recommendations with regard to designing an appropriate legal system with a strong focus on promoting access to medicine for all.

Introduction.- Test Data Exclusivity: Raison d'être.- Test Data Exclusivity and Art 39(3) TRIPS.- Test Data Exclusivity in the US and the EU.- Index of Data Exclusivity and Access (IDEAS) - Free Trade Agreements.- Index of Data Exclusivity and Access (IDEAS) - National Laws.- Test Data Exclusivity in FTAs and Access to Originator Pharmaceuticals.- Conclusions and Recommendations.

Erscheinungsdatum
Reihe/Serie Munich Studies on Innovation and Competition
Zusatzinfo XVI, 256 p. 78 illus., 56 illus. in color.
Verlagsort Berlin
Sprache englisch
Maße 155 x 235 mm
Gewicht 4161 g
Themenwelt Recht / Steuern Allgemeines / Lexika
Recht / Steuern EU / Internationales Recht
Recht / Steuern Öffentliches Recht
Recht / Steuern Privatrecht / Bürgerliches Recht Medienrecht
Recht / Steuern Wirtschaftsrecht
Schlagworte Access to medicine • Data exclusivity • Free Trade Agreements • Intellectual Property • TRIPS Agreement
ISBN-10 3-662-57021-1 / 3662570211
ISBN-13 978-3-662-57021-0 / 9783662570210
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Vorschriftensammlung

von Frank Fechner; Johannes C. Mayer

Buch | Softcover (2023)
C.F. Müller (Verlag)
CHF 41,95
Recherche, Darstellung und Haftung im Recht der Medien
Buch | Hardcover (2024)
Verlag Dr. Otto Schmidt KG
CHF 179,95
Lehrbuch des gesamten Medienrechts unter besonderer Berücksichtigung …

von Frank Fechner

Buch | Softcover (2023)
UTB (Verlag)
CHF 30,80